InvestorsHub Logo
Followers 16
Posts 1524
Boards Moderated 0
Alias Born 08/09/2011

Re: diannedawn post# 719

Tuesday, 04/21/2015 2:59:51 PM

Tuesday, April 21, 2015 2:59:51 PM

Post# of 4218
Well.......Hi Dianne. The deadline was supposed to be Feb. 15. Bill Wells informed us that the FDA was still reviewing new data. LuViva has a much larger market potential than NEPH's lead product. I certainly expect LuV to carry GTHP well beyond NEPH's .65 share price. We just have to wait it out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News